Dimethylformamide → 8-(1-t-Butyloxycarbonyl-1,2,5,6-tetrahydropyridin-4-yl)isoquinoline
반응식
Br[C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[CH:10]=[N:9][CH:8]=[CH:7]2.[C:12](=[O:15])([O-])[O-:13].[K+].[K+].[CH3:18][N:19]([CH:21]=O)C>C(Cl)Cl.[CH-]1C=C(P(C2C=CC=CC=2)C2C=CC=CC=2)C=C1.[CH-]1C=C(P(C2C=CC=CC=2)C2C=CC=CC=2)C=C1.Cl[Pd]Cl.[Fe+2]>[C:6]([O:13][C:12]([N:19]1[CH2:21][CH2:4][C:3]([C:2]2[CH:3]=[CH:4][CH:5]=[C:6]3[C:11]=2[CH:10]=[N:9][CH:8]=[CH:7]3)=[CH:2][CH2:18]1)=[O:15])([CH3:11])([CH3:7])[CH3:5]참가 물질
6
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 90 °C
실험 절차
8-Bromoisoquinoline (300 mg, 1.44 mmol) is dissolved in DMF (8.7 mL). To the solution is added Boc-piperidine boronic ester (405 mg, 1.31 mmol), dichloro(1,1′-bis(diphenylphosphino)ferrocene)palladium (II) dichloromethane adduct (58 mg, 0.079 mmol) and potassium carbonate (544 mg, 3.93 mmol). The mixture is heated to about 90° C. overnight and cooled, which is then diluted with DCM and filtered through celite. The filtrate is concentrated under vacuum to remove DCM and partitioned between EtOAc (100 mL), hexanes (100 mL) and water (100 mL). The organic fraction is concentrated and chromatographed on silica gel to give about 298 mg of 8-(1-t-butyloxycarbonyl-1,2,5,6-tetrahydropyridin-4-yl)isoquinoline (73%). EIS-MS 311.2 M+1
후처리
- temperaturecooled
- filtrationfiltered through celite
- concentrationThe filtrate is concentrated under vacuum
- customto remove DCM
- custompartitioned between EtOAc (100 mL), hexanes (100 mL) and water (100 mL)
- concentrationThe organic fraction is concentrated
- customchromatographed on silica gel
출처 및 근거
- ORD 기록
- ord-d00ee3b12e2e4e569ffb7cb9d556b86b
- 출처 데이터셋
- uspto-grants-2007_01
- 특허 번호
- US07157463B2
반응 노트
불러오는 중…